nach oben

Cancer and Metastasis Reviews

Erschienen in:

01.12.2010 | NON-THEMATIC REVIEW

Distant metastases do not metastasize

verfasst von: Dieter Hölzel, Renate Eckel, Rebecca T. Emeny, Jutta Engel

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Distant metastases (MET) are for most solid cancers decisive life-threatening events. Data about MET-free survival and survival after MET show a strong dependency on the kind of cancer and the prognostic features. Nonetheless, within biological subgroups, the MET process is very homogenous. Therefore, the growth rate can be estimated from initiation of MET to MET diagnosis and to time of death. Based on the known volume doubling time of breast cancer, the time of the first possible dissemination can also be estimated. Important consequences of these MET-initiation estimates are the hypotheses that almost all MET are initiated before removal of the primary tumor and that MET do not metastasize in a clinically relevant magnitude. Although breast cancer data were primarily used to form these hypotheses, the discussed MET process can be generalized to all solid cancers. The impact of these hypotheses on diagnostic, curative and palliative treatment, aftercare, and especially on clinical research would be important.

Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews. Cancer, 2(8), 563–572. doi:10.1038/nrc865.CrossRefPubMed

Fidler, I. J. (2003). The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nature Reviews. Cancer, 3(6), 453–458. doi:10.1038/nrc1098.CrossRefPubMed

Munich Cancer Registry. http://www.Tumorregister-muenchen.De/facts/specific_analysis.Php.

Curado, M., Edwards, B., Shin, H., Storm, H., Ferlay, J., Heanue, M., et al. (2007). Cancer incidence in five continents, vol. Ix. Lyon: IARC Scientific Publication No.160.

Nguyen, D. X., Bos, P. D., & Massague, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nature Reviews. Cancer, 9(4), 274–284. doi:10.1038/nrc2622.CrossRefPubMed

Weinberg, R. (2007). The biology of cancer. New York: Garland Science.

Sugarbaker, E. V., Cohen, A. M., & Ketcham, A. S. (1971). Do metastases metastasize? Annals of Surgery, 174(2), 161–166.CrossRefPubMed

Tait, C. R., Dodwell, D., & Horgan, K. (2004). Do metastases metastasize? The Journal of Pathology, 203(1), 515–518. doi:10.1002/path.1544.CrossRefPubMed

Sobin, L., Gospodarowicz, M., & Wittekind, C. (Eds.). (2009). Uicc: TNM classification of malignant tumors (7th ed.). Wiley-Blackwell: New York.

10.

Leong, S. P., Cady, B., Jablons, D. M., Garcia-Aguilar, J., Reintgen, D., Jakub, J., et al. (2006). Clinical patterns of metastasis. Cancer and Metastasis Reviews, 25(2), 221–232. doi:10.1007/s10555-006-8502-8.CrossRefPubMed

11.

Sarfati, D., Blakely, T., & Pearce, N. (2010). Measuring cancer survival in populations: relative survival vs cancer-specific survival. International Journal of Epidemiology, 39(2), 598–610. doi:10.1093/ije/dyp392.CrossRefPubMed

12.

Benson, J. R., & della Rovere, G. Q. (2007). Management of the axilla in women with breast cancer. The Lancet Oncology, 8(4), 331–348. doi:10.1016/S1470-2045(07)70103-1.CrossRefPubMed

13.

Michaelson, J. S., Silverstein, M., Wyatt, J., Weber, G., Moore, R., Halpern, E., et al. (2002). Predicting the survival of patients with breast carcinoma using tumor size. Cancer, 95(4), 713–723. doi:10.1002/cncr.10742.CrossRefPubMed

14.

Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., et al. (2000). Molecular portraits of human breast tumours. Nature, 406(6797), 747–752. doi:10.1038/35021093.CrossRefPubMed

15.

Sotiriou, C., & Pusztai, L. (2009). Gene-expression signatures in breast cancer. The New England Journal of Medicine, 360(8), 790–800. doi:10.1056/NEJMra0801289.CrossRefPubMed

16.

Bernards, R., & Weinberg, R. A. (2002). A progression puzzle. Nature, 418(6900), 823. doi:10.1038/418823a.CrossRefPubMed

17.

Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., et al. (2006). Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clinical Cancer Research, 12(19), 5615–5621. doi:10.1158/1078-0432.CCR-06-0169.CrossRefPubMed

18.

Clarke, M. F., & Fuller, M. (2006). Stem cells and cancer: two faces of eve. Cell, 124(6), 1111–1115. doi:10.1016/j.cell.2006.03.011.CrossRefPubMed

19.

Chojniak, R., & Younes, R. N. (2003). Pulmonary metastases tumor doubling time: assessment by computed tomography. American Journal of Clinical Oncology, 26(4), 374–377. doi:10.1097/01.COC.0000026481.38654.52.CrossRefPubMed

20.

Finlay, I. G., Meek, D., Brunton, F., & McArdle, C. S. (1988). Growth rate of hepatic metastases in colorectal carcinoma. The British Journal of Surgery, 75(7), 641–644.CrossRefPubMed

21.

Peer, P. G., van Dijck, J. A., Hendriks, J. H., Holland, R., & Verbeek, A. L. (1993). Age-dependent growth rate of primary breast cancer. Cancer, 71(11), 3547–3551.CrossRefPubMed

22.

Kuroishi, T., Tominaga, S., Morimoto, T., Tashiro, H., Itoh, S., Watanabe, H., et al. (1990). Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Japanese Journal of Cancer Research, 81(5), 454–462.PubMed

23.

Richards, M. A., Westcombe, A. M., Love, S. B., Littlejohns, P., & Ramirez, A. J. (1999). Influence of delay on survival in patients with breast cancer: a systematic review. Lancet, 353(9159), 1119–1126. doi:S0140673699021431.CrossRefPubMed

24.

Engel, J., Eckel, R., Kerr, J., Schmidt, M., Furstenberger, G., Richter, R., et al. (2003). The process of metastasisation for breast cancer. European Journal of Cancer, 39(12), 1794–1806. doi:S0959804903004222.CrossRefPubMed

25.

Aguirre-Ghiso, J. A. (2007). Models, mechanisms and clinical evidence for cancer dormancy. Nature Reviews. Cancer, 7(11), 834–846. doi:10.1038/nrc2256.CrossRefPubMed

26.

Naumov, G. N., Folkman, J., Straume, O., & Akslen, L. A. (2008). Tumor-vascular interactions and tumor dormancy. APMIS, 116(7–8), 569–585. doi:10.1111/j.1600-0463.2008.01213.x.CrossRefPubMed

27.

Husemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., et al. (2008). Systemic spread is an early step in breast cancer. Cancer Cell, 13(1), 58–68. doi:10.1016/j.ccr.2007.12.003.CrossRefPubMed

28.

Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., et al. (2004). Circulating tumor cells in patients with breast cancer dormancy. Clinical Cancer Research, 10(24), 8152–8162. doi:10.1158/1078-0432.CCR-04-1110.CrossRefPubMed

29.

Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., et al. (2004). Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England Journal of Medicine, 351(8), 781–791. doi:10.1056/NEJMoa040766.CrossRefPubMed

30.

Pachmann, K., Camara, O., Kavallaris, A., Krauspe, S., Malarski, N., Gajda, M., et al. (2008). Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. Journal of Clinical Oncology, 26(8), 1208–1215. doi:10.1200/JCO.2007.13.6523.CrossRefPubMed

31.

Townson, J. L., & Chambers, A. F. (2006). Dormancy of solitary metastatic cells. Cell Cycle, 5(16), 1744–1750. doi:2864.PubMed

32.

Wikman, H., Vessella, R., & Pantel, K. (2008). Cancer micrometastasis and tumour dormancy. APMIS, 116(7–8), 754–770. doi:10.1111/j.1600-0463.2008.01033.x.CrossRefPubMed

33.

Birkeland, S. A., & Storm, H. H. (2002). Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation, 74(10), 1409–1413. doi:10.1097/01.TP.0000034717.19606.B5.CrossRefPubMed

34.

Logan, P. T., Fernandes, B. F., Di Cesare, S., Marshall, J. C., Maloney, S. C., & Burnier, M. N., Jr. (2008). Single-cell tumor dormancy model of uveal melanoma. Clinical & Experimental Metastasis, 25(5), 509–516. doi:10.1007/s10585-008-9158-2.CrossRef

35.

Heyn, C., Ronald, J. A., Ramadan, S. S., Snir, J. A., Barry, A. M., MacKenzie, L. T., et al. (2006). In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magnetic Resonance in Medicine, 56(5), 1001–1010. doi:10.1002/mrm.21029.CrossRefPubMed

36.

Hölzel, D., Eckel, R., & Engel, J. (2009). [Colorectal cancer metastasis: frequency, prognosis, and consequences]. Chirurg, 80(4), 331–340. doi:10.1007/s00104-008-1603-x.CrossRefPubMed

37.

Kim, M. Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H., Norton, L., et al. (2009). Tumor self-seeding by circulating cancer cells. Cell, 139(7), 1315–1326. doi:10.1016/j.cell.2009.11.025.CrossRefPubMed

38.

Fisher, B., Anderson, S., Fisher, E. R., Redmond, C., Wickerham, D. L., Wolmark, N., et al. (1991). Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet, 338(8763), 327–331.CrossRefPubMed

39.

Fisher, B., & Anderson, S. J. (2010). The breast cancer alternative hypothesis: is there evidence to justify replacing it? Journal of Clinical Oncology, 28(3), 366–374. doi:10.1200/JCO.2009.26.8292.CrossRefPubMed

40.

Chambers, A. F., Naumov, G. N., Vantyghem, S. A., & Tuck, A. B. (2000). Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Research, 2(6), 400–407.CrossRefPubMed

41.

Glaves, D., Huben, R. P., & Weiss, L. (1988). Haematogenous dissemination of cells from human renal adenocarcinomas. British Journal of Cancer, 57(1), 32–35.PubMed

42.

van de Vijver, M. J., He, Y. D., van’t Veer, L. J., Dai, H., Hart, A. A., Voskuil, D. W., et al. (2002). A gene-expression signature as a predictor of survival in breast cancer. The New England Journal of Medicine, 347(25), 1999–2009. doi:10.1056/NEJMoa021967.CrossRefPubMed

43.

Bos, P. D., Zhang, X. H., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., et al. (2009). Genes that mediate breast cancer metastasis to the brain. Nature, 459(7249), 1005–1009. doi:10.1038/nature08021.CrossRefPubMed

44.

Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., et al. (2007). The prognostic role of a gene signature from tumorigenic breast-cancer cells. The New England Journal of Medicine, 356(3), 217–226. doi:10.1056/NEJMoa063994.CrossRefPubMed

45.

Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordon-Cardo, C., et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell, 3(6), 537–549. doi:S1535610803001326.CrossRefPubMed

46.

Fisher, B. (1980). Laboratory and clinical research in breast cancer—a personal adventure: the David A. Karnofsky memorial lecture. Cancer Research, 40(11), 3863–3874.PubMed

47.

Talmadge, J. E., Wolman, S. R., & Fidler, I. J. (1982). Evidence for the clonal origin of spontaneous metastases. Science, 217(4557), 361–363.CrossRefPubMed

48.

Fidler, I. J. (1973). The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. European Journal of Cancer, 9(3), 223–227.PubMed

49.

Klein, C. A. (2009). Parallel progression of primary tumours and metastases. Nature Reviews. Cancer, 9(4), 302–312. doi:10.1038/nrc2627.CrossRefPubMed

50.

Pantel, K., & Brakenhoff, R. H. (2004). Dissecting the metastatic cascade. Nature Reviews. Cancer, 4(6), 448–456. doi:10.1038/nrc1370.CrossRefPubMed

51.

Palmieri, D., Chambers, A. F., Felding-Habermann, B., Huang, S., & Steeg, P. S. (2007). The biology of metastasis to a sanctuary site. Clinical Cancer Research, 13(6), 1656–1662. doi:10.1158/1078-0432.CCR-06-2659.CrossRefPubMed

52.

Mehta, M. P., Tsao, M. N., Whelan, T. J., Morris, D. E., Hayman, J. A., Flickinger, J. C., et al. (2005). The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. International Journal of Radiation Oncology, Biology, Physics, 63(1), 37–46. doi:10.1016/j.ijrobp.2005.05.023.PubMed

53.

Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., et al. (2006). Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA, 295(21), 2483–2491. doi:10.1001/jama.295.21.2483.CrossRefPubMed

54.

Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995). Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Natural Medicines, 1(2), 149–153.CrossRef

55.

Steeg, P. S. (2006). Tumor metastasis: mechanistic insights and clinical challenges. Natural Medicines, 12(8), 895–904. doi:10.1038/nm1469.CrossRef

56.

Adjuvant tamoxifen in the management of operable breast cancer: the Scottish Trial. Report from the Breast Cancer Trials Committee, Scottish Cancer Trials Office (MRC) Edinburgh (1987). Lancet, 2(8552), 171–175. doi:S0140-6736(87)90762-8.

57.

de Boer, M., van Deurzen, C. H., van Dijck, J. A., Borm, G. F., van Diest, P. J., Adang, E. M., et al. (2009). Micrometastases or isolated tumor cells and the outcome of breast cancer. The New England Journal of Medicine, 361(7), 653–663. doi:10.1056/NEJMoa0904832.CrossRefPubMed

58.

Veronesi, U., Marubini, E., Mariani, L., Valagussa, P., & Zucali, R. (1999). The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. European Journal of Cancer, 35(9), 1320–1325. doi:S0959-8049(99)00133-1.CrossRefPubMed

59.

Fisher, B., Anderson, S., Bryant, J., Margolese, R. G., Deutsch, M., Fisher, E. R., et al. (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. The New England Journal of Medicine, 347(16), 1233–1241. doi:10.1056/NEJMoa022152.CrossRefPubMed

60.

Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., et al. (2006). Sentinel-node biopsy or nodal observation in melanoma. The New England Journal of Medicine, 355(13), 1307–1317. doi:10.1056/NEJMoa060992.CrossRefPubMed

61.

Hartgrink, H. H., van de Velde, C. J., Putter, H., Bonenkamp, J. J., Klein Kranenbarg, E., Songun, I., et al. (2004). Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. Journal of Clinical Oncology, 22(11), 2069–2077. doi:10.1200/JCO.2004.08.026.CrossRefPubMed

62.

Adam, R., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., et al. (2004). Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg, 240(4), 644–657. doi:00000658-200410000-00010. discussion 657–648.PubMed

63.

Fisher, B., & Fisher, E. R. (1966). Transmigration of lymph nodes by tumor cells. Science, 152(727), 1397–1398.CrossRefPubMed

64.

Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science, 321(5889), 699–702. doi:10.1126/science.1154884.CrossRefPubMed

65.

Zahl, P. H., Maehlen, J., & Welch, H. G. (2008). The natural history of invasive breast cancers detected by screening mammography. Archives of Internal Medicine, 168(21), 2311–2316. doi:10.1001/archinte.168.21.2311.CrossRefPubMed

66.

Chlebowski, R. T., Kuller, L. H., Prentice, R. L., Stefanick, M. L., Manson, J. E., Gass, M., et al. (2009). Breast cancer after use of estrogen plus progestin in postmenopausal women. The New England Journal of Medicine, 360(6), 573–587. doi:10.1056/NEJMoa0807684.CrossRefPubMed

67.

Paget, S. (1889). The distribution of secondary growths in cancer of the breast. Lancet, 1, 571–573.CrossRef

68.

Naumov, G. N., Wilson, S. M., MacDonald, I. C., Schmidt, E. E., Morris, V. L., Groom, A. C., et al. (1999). Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. Journal of Cell Science, 112(Pt 12), 1835–1842.PubMed

69.

Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E., Goldbrunner, R., Herms, J., et al. (2010). Real-time imaging reveals the single steps of brain metastasis formation. Nature Medicine, 16(1), 116–122. doi:10.1038/nm.2072.CrossRefPubMed

70.

Hoon, D. S., Kitago, M., Kim, J., Mori, T., Piris, A., Szyfelbein, K., et al. (2006). Molecular mechanisms of metastasis. Cancer and Metastasis Reviews, 25(2), 203–220. doi:10.1007/s10555-006-8500-x.CrossRefPubMed

Titel: Distant metastases do not metastasize
verfasst von: Dieter Hölzel
Renate Eckel
Rebecca T. Emeny
Jutta Engel
Publikationsdatum: 01.12.2010
Verlag: Springer US
Erschienen in: Cancer and Metastasis Reviews / Ausgabe 4/2010
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-010-9260-1

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Distant metastases do not metastasize

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2010

Obesity and breast cancer: status of leptin and adiponectin in pathological processes

Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis

The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network

Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie